How sleep and circadian timing affect heart and metabolic health in teens with type 1 diabetes
Mechanisms underlying the relationship between sleep health and circadian timing with cardiometabolic risk in adolescents with type 1 diabetes
This study is looking at how better sleep and a regular daily schedule can help teenagers with type 1 diabetes stay healthier and lower their risk of heart and metabolic problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10948592 on NIH RePORTER |
What this research studies
This research investigates the connection between sleep health, circadian timing, and cardiometabolic risk in adolescents with type 1 diabetes. The study aims to understand how improving sleep and aligning circadian rhythms can potentially reduce health risks associated with diabetes. By employing a combination of behavioral and physiological interventions, the researchers hope to enhance sleep duration and advance circadian timing in these adolescents. The ultimate goal is to identify effective strategies to improve overall cardiometabolic health in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 years who have been diagnosed with type 1 diabetes.
Not a fit: Patients who do not have type 1 diabetes or are outside the age range of 12 to 20 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved heart and metabolic health outcomes for adolescents with type 1 diabetes.
How similar studies have performed: Previous research has shown success in improving sleep and circadian timing in adolescents without diabetes, but this specific approach in adolescents with type 1 diabetes is novel.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Simon, Stacey Lynn — University of Colorado Denver
- Study coordinator: Simon, Stacey Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.